Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophrenia

Schizophr Res. 2003 Jan 1;59(1):97-8. doi: 10.1016/s0920-9964(01)00396-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Double-Blind Method
  • Eicosapentaenoic Acid
  • Fatty Acids, Unsaturated / therapeutic use*
  • Humans
  • Schizophrenia / therapy*

Substances

  • Fatty Acids, Unsaturated
  • Eicosapentaenoic Acid